In RCC, ZEB2 enhances the migratory and invasive ability of cells and the expression of ZEB2 correlates with more advanced forms of the disease and worse survival rates (see the review by Piva et al., 2016). This evidence concerns the gene ZEB2 and renal cell carcinoma.